148 related articles for article (PubMed ID: 31678046)
1. Agonism of GPR39 displays protective effects against advanced glycation end-product (AGE)-induced degradation of extracellular matrix in human SW1353 cells.
Shan W; Qi J; Li C; Nie X
Arch Biochem Biophys; 2019 Nov; 677():108164. PubMed ID: 31678046
[TBL] [Abstract][Full Text] [Related]
2. The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type Ⅱ collagen and aggrecan in human SW1353 chondrocytes.
Li H; Chen J; Li B; Fang X
Chem Biol Interact; 2020 May; 322():108968. PubMed ID: 32004530
[TBL] [Abstract][Full Text] [Related]
3. Salicin inhibits AGE-induced degradation of type II collagen and aggrecan in human SW1353 chondrocytes: therapeutic potential in osteoarthritis.
Gao F; Zhang S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1043-1049. PubMed ID: 30942091
[TBL] [Abstract][Full Text] [Related]
4. Saxagliptin suppresses degradation of type II collagen and aggrecan in primary human chondrocytes: a therapeutic implication in osteoarthritis.
Hu N; Gong X; Yin S; Li Q; Chen H; Li Y; Li F; Qing L; Yang J; Zhu S; Wang J; Li J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3239-3245. PubMed ID: 31364869
[TBL] [Abstract][Full Text] [Related]
5. Activation of GPR40 Suppresses AGE-Induced Reduction of Type II Collagen and Aggrecan in Human SW1353 Chondrocytes.
Gu J; Lin H; Zhang Y; Xu T; Wang T; Xue X; Zhang W; Liu H
Drug Des Devel Ther; 2020; 14():2371-2379. PubMed ID: 32606604
[TBL] [Abstract][Full Text] [Related]
6. Memantine inhibits degradation of the articular cartilage extracellular matrix induced by advanced glycation end products (AGEs).
Zhao J; Yu Y; Wu Z; Wang L; Li W
Biomed Pharmacother; 2017 Jul; 91():1193-1198. PubMed ID: 28545202
[TBL] [Abstract][Full Text] [Related]
7. Lixisenatide attenuates advanced glycation end products (AGEs)-induced degradation of extracellular matrix in human primary chondrocytes.
Li X; Jia F; Zhu Z; Huang L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1256-1264. PubMed ID: 30942623
[TBL] [Abstract][Full Text] [Related]
8. Activation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) inhibits degradation of type II collagen and aggrecan in human chondrocytes.
Zhuo W; Li B; Zhang D
Eur J Pharmacol; 2019 Aug; 856():172387. PubMed ID: 31075239
[TBL] [Abstract][Full Text] [Related]
9. Azilsartan prevented AGE-induced inflammatory response and degradation of aggrecan in human chondrocytes through inhibition of Sox4.
Lei J; He M; Xu L; He C; Li J; Wang W
J Biochem Mol Toxicol; 2021 Aug; 35(8):e22827. PubMed ID: 34051020
[TBL] [Abstract][Full Text] [Related]
10. The protective effects of bexarotene against advanced glycation end-product (AGE)-induced degradation of articular extracellular matrix (ECM).
Zha Z; Han Q; Huo S
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):1-7. PubMed ID: 31852246
[TBL] [Abstract][Full Text] [Related]
11. Vildagliptin reduced extracellular matrix degradation in human primary chondrocytes.
Wang Z; Xu M; Bai J; Ge G; Guo X; Yu B; Xiao L; Geng D; Hao Y
Eur J Pharmacol; 2019 Feb; 844():49-55. PubMed ID: 30452909
[TBL] [Abstract][Full Text] [Related]
12. The protective effects of the GPR39 agonist TC-G 1008 against TNF-α-induced inflammation in human fibroblast-like synoviocytes (FLSs).
Jing W; Sun W; Zhang N; Zhao C; Yan X
Eur J Pharmacol; 2019 Dec; 865():172663. PubMed ID: 31539553
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of gemigliptin against type II collagen degradation in human chondrocytes.
Mohetaer M; Li G; Wang Y; Cao L
Biomed Pharmacother; 2018 Aug; 104():590-594. PubMed ID: 29803171
[TBL] [Abstract][Full Text] [Related]
14. Agonism of GPR120 prevented IL-1β-induced reduction of extracellular matrix through SOX-9.
Xu Z; Ke T; Zhang Y; Fu C; He W
Aging (Albany NY); 2020 Jun; 12(12):12074-12085. PubMed ID: 32580167
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products cause collagen II reduction by activating Janus kinase/signal transducer and activator of transcription 3 pathway in porcine chondrocytes.
Huang CY; Lai KY; Hung LF; Wu WL; Liu FC; Ho LJ
Rheumatology (Oxford); 2011 Aug; 50(8):1379-89. PubMed ID: 21482542
[TBL] [Abstract][Full Text] [Related]
16. Ivabradine abrogates TNF-α-induced degradation of articular cartilage matrix.
Xiang X; Zhou Y; Sun H; Tan S; Lu Z; Huang L; Wang W
Int Immunopharmacol; 2019 Jan; 66():347-353. PubMed ID: 30521963
[TBL] [Abstract][Full Text] [Related]
17. Cabozantinib prevents AGEs-induced degradation of type 2 collagen and aggrecan in human chondrocytes.
Dong Y; Lin L; Ji Y; Cheng X; Zhang Z
Aging (Albany NY); 2023 Dec; 15(23):13646-13654. PubMed ID: 38059882
[TBL] [Abstract][Full Text] [Related]
18. Sodium butyrate abolishes the degradation of type II collagen in human chondrocytes.
Bo W; Zhou J; Wang K
Biomed Pharmacother; 2018 Jun; 102():1099-1104. PubMed ID: 29710527
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone inhibits advanced glycation end product-induced matrix metalloproteinases and apoptosis by suppressing the activation of MAPK and NF-κB.
Zhang HB; Zhang Y; Chen C; Li YQ; Ma C; Wang ZJ
Apoptosis; 2016 Oct; 21(10):1082-93. PubMed ID: 27515513
[TBL] [Abstract][Full Text] [Related]
20. Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes.
Kim JH; Huh JE; Baek YH; Lee JD; Choi DY; Park DS
J Ethnopharmacol; 2011 Mar; 134(2):234-42. PubMed ID: 21182922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
